builderall

  • At the conclusion of this activity, participants should be better able to:

  • Describe emerging oncology pharmacotherapy options and their mechanisms of action to support evidence-based treatment selection.

  • Evaluate patient- and drug-specific considerations for managing, monitoring, and adjusting oncology therapies to mitigate adverse effects and enhance therapeutic benefit.

  • Apply principles of precision medicine and molecular diagnostics to guide individualized cancer pharmacotherapy decision-making.

  • Develop strategies to improve adherence, optimize outcomes, and support transitions of care in oncology pharmacy practice.

  • Identify practice management innovations and operational efficiencies that enhance the value and sustainability of cancer care delivery.